Código QR (código de barras bidimensional)

Continuation, Resumption, and Withdrawal Rates of CGRP-mAb Treatment for Migraine Under Real-World Clinical Conditions in Which Patients Are Free to Choose Own Treatment

Background/Objectives: Anti-calcitonin gene-related peptide monoclonal antibodies (CGRP-mAbs) are effective injectable medications for the treatment of migraine. This study aimed to evaluate continuation, resumption, and withdrawal rates of CGRP-mAb treatment under real-world clinical conditions. Me...

Fuld beskrivelse

Na minha lista:
Principais autores: Takafumi Tanei, Satoshi Yamashita, Satoshi Maesawa, Yusuke Nishimura, Tomotaka Ishizaki, Yoshitaka Nagashima, Takahiro Suzuki, Hajime Hamasaki, Shun Yamamoto, Toshihiko Wakabayashi, Ryuta Saito
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2025-12-01
Serier:Neurology International
Fag:
CGRP
continuation
migraine
resumption
withdrawal
Online adgang:https://www.mdpi.com/2035-8377/18/1/3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker